Not applicableStudy completedNCT00427336What this trial is testingPurine Analog-Based Conditioning in Patients With Severe Aplastic AnemiaWho this might be right forAplastic Anemia M.D. Anderson Cancer Center 9
Large-scale testing (Phase 3)Study completedNCT00275665What this trial is testingThe Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection.Who this might be right forBone Marrow Stem Cell Transplant Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02396134What this trial is testingVaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more City of Hope Medical Center 61
Testing effectiveness (Phase 2)Study completedNCT04151706What this trial is testingCD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CMLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndromes+2 more Robert Lowsky 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT02323867What this trial is testingAllogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic MalignanciesWho this might be right forLeukemiaLymphomaMyelodysplasia Children's Hospital of Philadelphia 140
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT03121014What this trial is testingStudy of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic SyndromesWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes University of Illinois at Chicago 38
Not applicableActive Not RecruitingNCT03595787What this trial is testingCOaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Looking for participantsNCT05807932What this trial is testingVenetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAMLWho this might be right forMyelodysplastic SyndromesSecondary Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia Heinrich-Heine University, Duesseldorf 38
Testing effectiveness (Phase 2)Study completedNCT00721214What this trial is testing5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome Virginia Commonwealth University 16
Large-scale testing (Phase 3)UnknownNCT00002989What this trial is testingCombination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more European Organisation for Research and Treatment of Cancer - EORTC 207
Testing effectiveness (Phase 2)Looking for participantsNCT05800210What this trial is testingAlpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant DiseasesWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaJuvenile Myelomonocytic Leukemia+4 more University of Florida 20
Testing effectiveness (Phase 2)UnknownNCT00598624What this trial is testingClinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)Who this might be right forLeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome+4 more IRCCS San Raffaele 175
Not applicableEnded earlyNCT00185523What this trial is testingAllogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)Who this might be right forLeukemia, Lymphocytic, AcuteLeukemiaLeukemia Acute Promyelocytic Leukemia (APL)+4 more Stanford University 88
Testing effectiveness (Phase 2)Study completedNCT01384513What this trial is testingA Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological MalignanciesWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+44 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40
Testing effectiveness (Phase 2)Looking for participantsNCT03970096What this trial is testingGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)Who this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more Fred Hutchinson Cancer Center 120
Large-scale testing (Phase 3)Study completedNCT00001561What this trial is testingActive Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow TransplantationWho this might be right forGraft vs Host DiseaseMultiple Myeloma National Cancer Institute (NCI) 30
Not applicableStudy completedNCT00859586What this trial is testingMismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell TransplantationWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic National Heart, Lung, and Blood Institute (NHLBI) 8
Testing effectiveness (Phase 2)Looking for participantsNCT05805605What this trial is testingAllo HSCT Using RIC and PTCy for Hematological DiseasesWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more Masonic Cancer Center, University of Minnesota 56
Early research (Phase 1)WithdrawnNCT02274506What this trial is testingInfusion of Allogeneic, 3rd Party CD19-specific T CellsWho this might be right forBlood And Marrow TransplantationLeukemiaLymphoma M.D. Anderson Cancer Center